Company Data
Erasca Inc.
Ticker
ERAS
Current Price
$1.57 -0.63%
Market Cap
$445.4M
Price Target
Refer to Report
Volume
338.8K
52wk Range
$1.01 - $3.305
Overview
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company’s pipeline includes two clinical-stage programs (ERK and SHP2 inhibitors), two preclinical-stage programs (CNS-penetrant KRAS G12C and EGFR inhibitors), and seven discovery-stage programs targeting other key oncogenic drivers.